
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Different mutations in SARS-CoV-2 associate with severe and mild outcome
Ádám Nagy, Sándor Pongor, Balázs Győrffy
International Journal of Antimicrobial Agents (2020) Vol. 57, Iss. 2, pp. 106272-106272
Open Access | Times Cited: 144
Ádám Nagy, Sándor Pongor, Balázs Győrffy
International Journal of Antimicrobial Agents (2020) Vol. 57, Iss. 2, pp. 106272-106272
Open Access | Times Cited: 144
Showing 1-25 of 144 citing articles:
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
Maria Alice Freitas Queiroz, Pablo Fabiano Moura das Neves, Sandra Souza Lima, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 173
Maria Alice Freitas Queiroz, Pablo Fabiano Moura das Neves, Sandra Souza Lima, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 173
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
Chava Perry, Efrat Luttwak, R. Balaban, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3053-3061
Open Access | Times Cited: 159
Chava Perry, Efrat Luttwak, R. Balaban, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3053-3061
Open Access | Times Cited: 159
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 104
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 104
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 69
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 69
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
The Effects of COVID-19 on the Placenta During Pregnancy
Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 83
Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 83
Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System
Hélène Banoun
The Nephron journals/Nephron journals (2021) Vol. 145, Iss. 4, pp. 392-403
Open Access | Times Cited: 80
Hélène Banoun
The Nephron journals/Nephron journals (2021) Vol. 145, Iss. 4, pp. 392-403
Open Access | Times Cited: 80
SARS-CoV-2 mutations: the biological trackway towards viral fitness
Parinita Majumdar, Sougata Niyogi
Epidemiology and Infection (2021) Vol. 149
Open Access | Times Cited: 65
Parinita Majumdar, Sougata Niyogi
Epidemiology and Infection (2021) Vol. 149
Open Access | Times Cited: 65
SARS-CoV-2 Variants and Clinical Outcomes: A Systematic Review
Indira R. Mendiola‐Pastrana, Eduardo López‐Ortiz, José G. Río de la Loza-Zamora, et al.
Life (2022) Vol. 12, Iss. 2, pp. 170-170
Open Access | Times Cited: 60
Indira R. Mendiola‐Pastrana, Eduardo López‐Ortiz, José G. Río de la Loza-Zamora, et al.
Life (2022) Vol. 12, Iss. 2, pp. 170-170
Open Access | Times Cited: 60
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8
Xin Wu, Tian Xia, Woo-Jin Shin, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 56
Xin Wu, Tian Xia, Woo-Jin Shin, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 56
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19
Nicolas de Prost, Étienne Audureau, Nicholas Heming, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Nicolas de Prost, Étienne Audureau, Nicholas Heming, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
Thi Loi Dao, Van Thuan Hoang, Philippe Colson, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2635-2635
Open Access | Times Cited: 47
Thi Loi Dao, Van Thuan Hoang, Philippe Colson, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2635-2635
Open Access | Times Cited: 47
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Gabriela Athziri Sánchez‐Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González‐Estevez, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 44
Gabriela Athziri Sánchez‐Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González‐Estevez, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 44
SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions
Smita Vinjamuri, Lenong Li, Marlène Bouvier
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Smita Vinjamuri, Lenong Li, Marlène Bouvier
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 19
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 5
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 5
SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms
Marília Inês Móvio, Giovana Waner Carneiro de Almeida, Isabella das Graças Lopes Martines, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 161-161
Open Access | Times Cited: 5
Marília Inês Móvio, Giovana Waner Carneiro de Almeida, Isabella das Graças Lopes Martines, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 161-161
Open Access | Times Cited: 5
Prediction models for COVID-19 disease outcomes
Cynthia Y. Tang, Cheng Gao, Kritika Prasai, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Cynthia Y. Tang, Cheng Gao, Kritika Prasai, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
A comprehensive review of current insights into the virulence factors of SARS-CoV-2
Yi Wang, Bingqing Xia, Zhaobing Gao
Journal of Virology (2025)
Open Access
Yi Wang, Bingqing Xia, Zhaobing Gao
Journal of Virology (2025)
Open Access
Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022
Matilda Berkell, Anna Górska, Mathias Smet, et al.
Eurosurveillance (2025) Vol. 30, Iss. 10
Open Access
Matilda Berkell, Anna Górska, Mathias Smet, et al.
Eurosurveillance (2025) Vol. 30, Iss. 10
Open Access
Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging
Alejandro Flores-Alanis, Armando Cruz‐Rangel, Flor Rodríguez‐Gómez, et al.
Pathogens (2021) Vol. 10, Iss. 2, pp. 184-184
Open Access | Times Cited: 39
Alejandro Flores-Alanis, Armando Cruz‐Rangel, Flor Rodríguez‐Gómez, et al.
Pathogens (2021) Vol. 10, Iss. 2, pp. 184-184
Open Access | Times Cited: 39
Ruibang Luo, A Delaunay, Kenneth N. Timmis, et al.
Environmental Microbiology (2021) Vol. 23, Iss. 5, pp. 2339-2363
Open Access | Times Cited: 35
Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets
Jiantao Zhang, Qi Li, Ruth S. Cruz Cosme, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Jiantao Zhang, Qi Li, Ruth S. Cruz Cosme, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations
Bo Ning, Brady M. Youngquist, Diane D. Li, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 2, pp. 100173-100173
Open Access | Times Cited: 25
Bo Ning, Brady M. Youngquist, Diane D. Li, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 2, pp. 100173-100173
Open Access | Times Cited: 25